tiprankstipranks
Trending News
More News >
Heart Test Laboratories, Inc. (HSCS)
NASDAQ:HSCS
US Market

Heart Test Laboratories, Inc. (HSCS) Ratios

Compare
203 Followers

Heart Test Laboratories, Inc. Ratios

HSCS's free cash flow for Q3 2026 was $0.00. For the 2026 fiscal year, HSCS's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Apr 25Apr 24Apr 23Apr 22
Liquidity Ratios
Current Ratio
1.19K 0.59 4.20 1.47 0.56
Quick Ratio
1.04K 0.41 3.84 1.10 0.36
Cash Ratio
795.76 0.30 3.32 0.91 0.26
Solvency Ratio
-1.70 -2.15 -2.98 -2.07 -0.59
Operating Cash Flow Ratio
-1.35K -2.00 -3.47 -3.15 -1.05
Short-Term Operating Cash Flow Coverage
-1.78 -2.91 -12.14 -11.55 -2.24
Net Current Asset Value
$ 5.09B$ -1.85M$ 5.17M$ -360.10K$ -6.21M
Leverage Ratios
Debt-to-Assets Ratio
511.90 0.71 0.11 0.48 2.95
Debt-to-Equity Ratio
1.46K 14.55 0.14 6.79 -1.02
Debt-to-Capital Ratio
1.00 0.94 0.12 0.87 57.61
Long-Term Debt-to-Capital Ratio
0.14 0.00 0.00 0.68 -2.75
Financial Leverage Ratio
2.85 20.58 1.30 14.26 -0.35
Debt Service Coverage Ratio
>-0.01 -2.67 -7.21 -8.19 -2.21
Interest Coverage Ratio
-11.05 -16.69 -17.81 -25.14 -12.67
Debt to Market Cap
585.19 0.77 0.15 0.15 1.08
Interest Debt Per Share
1.22K 3.72 3.94 22.75 196.88
Net Debt to EBITDA
-61.40 -0.23 0.78 0.02 -1.18
Profitability Margins
Gross Profit Margin
-1060.25%-2884.71%-444.16%-476.91%-139.73%
EBIT Margin
-89802.27%-189994.85%-33608.22%-118662.45%-31007.03%
EBITDA Margin
-88318.72%-187053.33%-33096.75%-118139.83%-30822.19%
Operating Profit Margin
-89939.57%-192013.13%-33901.99%-118698.33%-32765.60%
Pretax Profit Margin
-97880.97%-201499.52%-35511.87%-123384.27%-33592.57%
Net Profit Margin
-97880.96%-201499.52%-35511.87%-123384.27%-33592.57%
Continuous Operations Profit Margin
-97880.97%-201499.52%-35511.87%-123384.27%-33592.57%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
108.83%104.94%104.75%103.95%102.52%
Return on Assets (ROA)
-112.32%-207.56%-69.51%-193.30%-231.08%
Return on Equity (ROE)
-333.38%-4272.16%-90.27%-2756.06%79.73%
Return on Capital Employed (ROCE)
-237.30%-1607.20%-81.35%-420.33%340.98%
Return on Invested Capital (ROIC)
-0.07%-261.80%-75.49%-308.13%-1385.74%
Return on Tangible Assets
0.51%-336.27%-83.46%-193.30%-231.08%
Earnings Yield
-105.23%-266.15%-202.78%-94.57%-85.58%
Efficiency Ratios
Receivables Turnover
0.00 1.00 0.00 0.00 6.19
Payables Turnover
0.24 0.41 0.23 0.05 0.05
Inventory Turnover
<0.01 0.20 0.16 0.04 0.05
Fixed Asset Turnover
<0.01 <0.01 0.03 <0.01 0.09
Asset Turnover
<0.01 <0.01 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
<0.01 <0.01 <0.01 -0.02 -0.03
Cash Conversion Cycle
2.38M 1.30K 652.71 552.70 -159.34
Days of Sales Outstanding
0.00 365.00 0.00 0.00 58.94
Days of Inventory Outstanding
2.39M 1.83K 2.27K 8.31K 7.14K
Days of Payables Outstanding
1.49K 895.83 1.62K 7.76K 7.36K
Operating Cycle
2.39M 2.19K 2.27K 8.31K 7.20K
Cash Flow Ratios
Operating Cash Flow Per Share
-1.82K -7.90 -17.22 -72.62 -109.80
Free Cash Flow Per Share
-1.82K -7.93 -17.57 -72.85 -109.86
CapEx Per Share
1.13 0.03 0.36 0.23 0.06
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.02 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-1.61K -245.56 -48.46 -315.36 -1.89K
Capital Expenditure Coverage Ratio
-1.61K -245.56 -48.46 -315.36 -1.89K
Operating Cash Flow Coverage Ratio
-1.49 -2.48 -5.86 -3.69 -0.59
Operating Cash Flow to Sales Ratio
-663.48K -1.70K -326.35 -1.12K -253.54
Free Cash Flow Yield
-104140.49%-226.01%-190.20%-86.20%-64.62%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.95 -0.38 -0.49 -1.06 -1.17
Price-to-Sales (P/S) Ratio
637.50 757.08 175.12 1.30K 392.55
Price-to-Book (P/B) Ratio
3.04 16.05 0.45 29.14 -0.93
Price-to-Free Cash Flow (P/FCF) Ratio
>-0.01 -0.44 -0.53 -1.16 -1.55
Price-to-Operating Cash Flow Ratio
>-0.01 -0.44 -0.54 -1.16 -1.55
Price-to-Earnings Growth (PEG) Ratio
-0.03 <0.01 <0.01 >-0.01 -0.02
Price-to-Fair Value
3.04 16.05 0.45 29.14 -0.93
Enterprise Value Multiple
-62.12 -0.64 0.25 -1.09 -2.46
Enterprise Value
475.62M 5.18M -1.51M 6.62M 10.89M
EV to EBITDA
-62.12 -0.64 0.25 -1.09 -2.46
EV to Sales
54.86K 1.19K -81.40 1.29K 757.44
EV to Free Cash Flow
-0.08 -0.70 0.24 -1.14 -2.99
EV to Operating Cash Flow
-0.08 -0.70 0.25 -1.15 -2.99
Tangible Book Value Per Share
-523.21 -1.50 16.25 2.90 -182.46
Shareholders’ Equity Per Share
0.84 0.22 20.76 2.90 -182.46
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 <0.01 0.05 0.06 0.43
Net Income Per Share
-2.68 -9.34 -18.74 -79.92 -145.48
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.09 1.06 1.06 1.04 1.08
Research & Development to Revenue
73.97K 1.01K 154.76 477.84 208.83
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
113.93K 57.44 21.78 48.22 4.76
Income Quality
0.90 0.85 0.92 0.91 0.75
Currency in USD